期刊文献+

青年人和老年人大肠癌的比较研究 被引量:20

Comparative Study in Young and Old Patients with Colorectal Cancer
暂未订购
导出
摘要 目的 探讨青年人和老年人大肠癌的临床及病理特征。方法 对 14 7例青年人和老年人大肠癌患者的临床特征进行分析 ,测定患者血清CEA、CA2 4 2 ,采用免疫组化方法测定其 p5 3、c erbB2和CD44V 6蛋白的表达情况。 结果 青年组和老年组大肠癌在性别分布上无差异 ,2组中直肠癌均多于结肠癌 (P >0 .0 5 ) ,而青年组肿瘤细胞多数分化程度差 (低 未分化 ) ,老年组肿瘤细胞分化程度较好 (高 中分化 ) ;青年组病程较晚 (Duke′sC +D)病例的比例较老年组高 (P <0 .0 5 ) ;青年组和老年组CEA、CA2 4 2 、p5 3、c erbB2、CD 44V 6的阳性率分别为 34.1%、5 6 .1%、5 3 .7%、5 6 .1%、36 .6 %和 19.8%、2 3 .6 %、33 .0 %、37.7%、17.9% ,除CEA外 ,其余 4项指标 ,2组比较均有显著性差异 (P <0 .0 5 )。 Objective To study the clinical and pathological characters of young and old patients with colorectal cancer.Methods Clinical Characteristics of 41 young and 106 old patients with colorectal cancer were analyzed.Serum CEA and CA 242 levels were measured.p53 c erbB 2 and CD44V6 protein were detected by immunohistochemistry methods in all patients.Results There was no significant difference in sex and site of colorectal cancer between young and old patients.The rates of poor differentiated tumor cell and advanced stage(Duke′s C+D) in young patients were higher than those in old patients( P <0.05).The positive rate of CEA、CA 242 、p53、c erbB 2 、CD44V6 in young and old patients was 34.1%、56.1%、53.7%、56.1%、36.6% and 19.8%、23.5%、 33.0% 、37.7%、17.9% respectively.There were significant difference between young and old one in four items except CEA( P < 0.05 ).Conclusion There are different clinical charateristics and biological behavior between young and old patients with colorectal cancer.
出处 《实用癌症杂志》 2001年第1期70-71,83,共3页 The Practical Journal of Cancer
关键词 大肠癌 P53蛋白 C-ERBB2蛋白 CD44V6蛋白 青年 Colorectal neoplasms p53 protein c erbB 2 protein CD44V6 protein
  • 相关文献

参考文献8

  • 1[1]Ratto C, Sofo L, Ippoliti M,et al. Prognostic factors in colorectal cancer [J ]. Dis Colon Rectum, 1998, 41 ( 8 ):1033.
  • 2[2]Lanza G, Gafa R, Santini A, et al. Prognostic significance of DNA ploidy in patients with stage Ⅱ and stage Ⅲcolon carcinoma[J ]. Cancer, 1998,82(1) :49.
  • 3[3]Lucha PA, Rosen L, Olenwine JA, et al. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma [J ]. Dis Colon Rectum,1997,40(2) : 145.
  • 4[4]Nilsson D,Johansson C,Glimelins B,et al. Sensitivity and specitivity of CA242 in gastrointestinal cancer. A comparison with CEA. CA50 and CA19-9[J]. Br J Cancer, 1992,65(2) :215.
  • 5[5]Flamini G, Carigliano G, Ratto C, et al. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer[J]. Eur J Cancer, 1996,32A(5) :802.
  • 6[6]Poller DN,Baxter K J, Shepherd NA. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? [J ]. Br J Cancer, 1997,75 (1): 87.
  • 7[7]Mulder JWR, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins[J ]. Lancet, 1994,344(11): 1470.
  • 8[8]Herrlich P, Pals S, Ponta H. CD44 in colon cancer[J ]. Eur J Cancer, 1995,31A(7~8) : 1110.

同被引文献88

引证文献20

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部